nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—PTGS2—stomach cancer	0.345	1	CbGaD
Etoricoxib—CYP2C9—Capecitabine—stomach cancer	0.0283	0.296	CbGbCtD
Etoricoxib—CYP1A2—Fluorouracil—stomach cancer	0.0186	0.195	CbGbCtD
Etoricoxib—CYP2C9—Fluorouracil—stomach cancer	0.0168	0.175	CbGbCtD
Etoricoxib—CYP3A4—Irinotecan—stomach cancer	0.0102	0.106	CbGbCtD
Etoricoxib—CYP2D6—Doxorubicin—stomach cancer	0.00874	0.0913	CbGbCtD
Etoricoxib—CYP3A4—Docetaxel—stomach cancer	0.00745	0.0779	CbGbCtD
Etoricoxib—MAPK14—blood vessel—stomach cancer	0.00664	0.111	CbGeAlD
Etoricoxib—CYP3A4—Doxorubicin—stomach cancer	0.00556	0.0581	CbGbCtD
Etoricoxib—MAPK14—hematopoietic system—stomach cancer	0.00354	0.0593	CbGeAlD
Etoricoxib—MAPK14—epithelium—stomach cancer	0.00323	0.0542	CbGeAlD
Etoricoxib—MAPK14—smooth muscle tissue—stomach cancer	0.00312	0.0523	CbGeAlD
Etoricoxib—Celecoxib—CA2—stomach cancer	0.00272	0.433	CrCbGaD
Etoricoxib—MAPK14—lymphoid tissue—stomach cancer	0.00249	0.0418	CbGeAlD
Etoricoxib—MAPK14—digestive system—stomach cancer	0.00246	0.0413	CbGeAlD
Etoricoxib—MAPK14—bone marrow—stomach cancer	0.00227	0.038	CbGeAlD
Etoricoxib—MAPK14—endocrine gland—stomach cancer	0.00203	0.0341	CbGeAlD
Etoricoxib—PTGS2—blood vessel—stomach cancer	0.00191	0.032	CbGeAlD
Etoricoxib—MAPK14—liver—stomach cancer	0.00183	0.0307	CbGeAlD
Etoricoxib—PTGS2—gall bladder—stomach cancer	0.0018	0.0301	CbGeAlD
Etoricoxib—CYP2C19—hematopoietic system—stomach cancer	0.0015	0.0252	CbGeAlD
Etoricoxib—MAPK14—lymph node—stomach cancer	0.0014	0.0236	CbGeAlD
Etoricoxib—Vemurafenib—ALB—stomach cancer	0.00129	0.206	CrCbGaD
Etoricoxib—CYP1A2—hematopoietic system—stomach cancer	0.00123	0.0206	CbGeAlD
Etoricoxib—CYP2C9—hematopoietic system—stomach cancer	0.00117	0.0195	CbGeAlD
Etoricoxib—CYP2E1—hematopoietic system—stomach cancer	0.0011	0.0185	CbGeAlD
Etoricoxib—CYP2C19—digestive system—stomach cancer	0.00105	0.0175	CbGeAlD
Etoricoxib—PTGS2—hematopoietic system—stomach cancer	0.00102	0.0171	CbGeAlD
Etoricoxib—PTGS2—epithelium—stomach cancer	0.00093	0.0156	CbGeAlD
Etoricoxib—PTGS2—smooth muscle tissue—stomach cancer	0.000896	0.015	CbGeAlD
Etoricoxib—CYP3A4—hematopoietic system—stomach cancer	0.000889	0.0149	CbGeAlD
Etoricoxib—CYP2D6—hematopoietic system—stomach cancer	0.000875	0.0147	CbGeAlD
Etoricoxib—CYP2C19—endocrine gland—stomach cancer	0.000864	0.0145	CbGeAlD
Etoricoxib—CYP1A2—digestive system—stomach cancer	0.000854	0.0143	CbGeAlD
Etoricoxib—Celecoxib—PTGS2—stomach cancer	0.000853	0.136	CrCbGaD
Etoricoxib—PTGS2—pancreas—stomach cancer	0.000828	0.0139	CbGeAlD
Etoricoxib—CYP2C9—digestive system—stomach cancer	0.000811	0.0136	CbGeAlD
Etoricoxib—CYP2C19—liver—stomach cancer	0.000779	0.0131	CbGeAlD
Etoricoxib—CYP2E1—lymphoid tissue—stomach cancer	0.000778	0.013	CbGeAlD
Etoricoxib—CYP2E1—digestive system—stomach cancer	0.000768	0.0129	CbGeAlD
Etoricoxib—Celecoxib—ALB—stomach cancer	0.00076	0.121	CrCbGaD
Etoricoxib—PTGS2—lymphoid tissue—stomach cancer	0.000716	0.012	CbGeAlD
Etoricoxib—PTGS2—digestive system—stomach cancer	0.000707	0.0119	CbGeAlD
Etoricoxib—CYP1A2—endocrine gland—stomach cancer	0.000706	0.0118	CbGeAlD
Etoricoxib—CYP2C9—endocrine gland—stomach cancer	0.00067	0.0112	CbGeAlD
Etoricoxib—PTGS2—bone marrow—stomach cancer	0.000652	0.0109	CbGeAlD
Etoricoxib—Vismodegib—ALB—stomach cancer	0.000651	0.104	CrCbGaD
Etoricoxib—CYP1A2—liver—stomach cancer	0.000636	0.0107	CbGeAlD
Etoricoxib—CYP2E1—endocrine gland—stomach cancer	0.000635	0.0106	CbGeAlD
Etoricoxib—CYP3A4—digestive system—stomach cancer	0.000618	0.0104	CbGeAlD
Etoricoxib—CYP2D6—digestive system—stomach cancer	0.000608	0.0102	CbGeAlD
Etoricoxib—CYP2C9—liver—stomach cancer	0.000604	0.0101	CbGeAlD
Etoricoxib—PTGS2—endocrine gland—stomach cancer	0.000584	0.0098	CbGeAlD
Etoricoxib—CYP2E1—liver—stomach cancer	0.000572	0.0096	CbGeAlD
Etoricoxib—PTGS2—liver—stomach cancer	0.000527	0.00884	CbGeAlD
Etoricoxib—CYP3A4—endocrine gland—stomach cancer	0.000511	0.00857	CbGeAlD
Etoricoxib—CYP2D6—endocrine gland—stomach cancer	0.000503	0.00843	CbGeAlD
Etoricoxib—CYP3A4—liver—stomach cancer	0.00046	0.00772	CbGeAlD
Etoricoxib—CYP2D6—liver—stomach cancer	0.000453	0.0076	CbGeAlD
Etoricoxib—PTGS2—lymph node—stomach cancer	0.000404	0.00678	CbGeAlD
Etoricoxib—Hepatitis—Epirubicin—stomach cancer	0.000169	0.00063	CcSEcCtD
Etoricoxib—Eye disorder—Methotrexate—stomach cancer	0.000169	0.000629	CcSEcCtD
Etoricoxib—Diarrhoea—Fluorouracil—stomach cancer	0.000168	0.000629	CcSEcCtD
Etoricoxib—Thrombocytopenia—Capecitabine—stomach cancer	0.000168	0.000629	CcSEcCtD
Etoricoxib—Tinnitus—Methotrexate—stomach cancer	0.000168	0.000628	CcSEcCtD
Etoricoxib—Hypoaesthesia—Epirubicin—stomach cancer	0.000168	0.000627	CcSEcCtD
Etoricoxib—Pharyngitis—Epirubicin—stomach cancer	0.000167	0.000625	CcSEcCtD
Etoricoxib—Cardiac disorder—Methotrexate—stomach cancer	0.000167	0.000625	CcSEcCtD
Etoricoxib—Skin disorder—Capecitabine—stomach cancer	0.000167	0.000624	CcSEcCtD
Etoricoxib—Urinary tract disorder—Epirubicin—stomach cancer	0.000167	0.000622	CcSEcCtD
Etoricoxib—Oedema peripheral—Epirubicin—stomach cancer	0.000166	0.000621	CcSEcCtD
Etoricoxib—Haematuria—Doxorubicin—stomach cancer	0.000166	0.000619	CcSEcCtD
Etoricoxib—Connective tissue disorder—Epirubicin—stomach cancer	0.000166	0.000619	CcSEcCtD
Etoricoxib—Urethral disorder—Epirubicin—stomach cancer	0.000165	0.000617	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000164	0.000614	CcSEcCtD
Etoricoxib—Epistaxis—Doxorubicin—stomach cancer	0.000164	0.000612	CcSEcCtD
Etoricoxib—Anorexia—Capecitabine—stomach cancer	0.000164	0.000612	CcSEcCtD
Etoricoxib—Angiopathy—Methotrexate—stomach cancer	0.000164	0.000611	CcSEcCtD
Etoricoxib—Vomiting—Irinotecan—stomach cancer	0.000163	0.00061	CcSEcCtD
Etoricoxib—Sinusitis—Doxorubicin—stomach cancer	0.000163	0.000609	CcSEcCtD
Etoricoxib—Immune system disorder—Methotrexate—stomach cancer	0.000163	0.000608	CcSEcCtD
Etoricoxib—Dizziness—Fluorouracil—stomach cancer	0.000163	0.000608	CcSEcCtD
Etoricoxib—Visual impairment—Epirubicin—stomach cancer	0.000163	0.000607	CcSEcCtD
Etoricoxib—Mediastinal disorder—Methotrexate—stomach cancer	0.000163	0.000607	CcSEcCtD
Etoricoxib—Rash—Irinotecan—stomach cancer	0.000162	0.000605	CcSEcCtD
Etoricoxib—Dermatitis—Irinotecan—stomach cancer	0.000162	0.000605	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000162	0.000605	CcSEcCtD
Etoricoxib—Headache—Irinotecan—stomach cancer	0.000161	0.000601	CcSEcCtD
Etoricoxib—Insomnia—Docetaxel—stomach cancer	0.000161	0.0006	CcSEcCtD
Etoricoxib—Erythema multiforme—Epirubicin—stomach cancer	0.00016	0.000596	CcSEcCtD
Etoricoxib—Alopecia—Methotrexate—stomach cancer	0.000159	0.000595	CcSEcCtD
Etoricoxib—Dyspnoea—Docetaxel—stomach cancer	0.000158	0.000592	CcSEcCtD
Etoricoxib—Somnolence—Docetaxel—stomach cancer	0.000158	0.00059	CcSEcCtD
Etoricoxib—Mental disorder—Methotrexate—stomach cancer	0.000158	0.00059	CcSEcCtD
Etoricoxib—Eye disorder—Epirubicin—stomach cancer	0.000158	0.000589	CcSEcCtD
Etoricoxib—Tinnitus—Epirubicin—stomach cancer	0.000157	0.000587	CcSEcCtD
Etoricoxib—Erythema—Methotrexate—stomach cancer	0.000157	0.000586	CcSEcCtD
Etoricoxib—Malnutrition—Methotrexate—stomach cancer	0.000157	0.000586	CcSEcCtD
Etoricoxib—Haemoglobin—Doxorubicin—stomach cancer	0.000157	0.000586	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000157	0.000585	CcSEcCtD
Etoricoxib—Flushing—Epirubicin—stomach cancer	0.000157	0.000585	CcSEcCtD
Etoricoxib—Cardiac disorder—Epirubicin—stomach cancer	0.000157	0.000585	CcSEcCtD
Etoricoxib—Vomiting—Fluorouracil—stomach cancer	0.000157	0.000584	CcSEcCtD
Etoricoxib—Dyspepsia—Docetaxel—stomach cancer	0.000156	0.000584	CcSEcCtD
Etoricoxib—Haemorrhage—Doxorubicin—stomach cancer	0.000156	0.000583	CcSEcCtD
Etoricoxib—Hepatitis—Doxorubicin—stomach cancer	0.000156	0.000583	CcSEcCtD
Etoricoxib—Insomnia—Capecitabine—stomach cancer	0.000156	0.000581	CcSEcCtD
Etoricoxib—Hypoaesthesia—Doxorubicin—stomach cancer	0.000155	0.00058	CcSEcCtD
Etoricoxib—Rash—Fluorouracil—stomach cancer	0.000155	0.00058	CcSEcCtD
Etoricoxib—Dermatitis—Fluorouracil—stomach cancer	0.000155	0.000579	CcSEcCtD
Etoricoxib—Pharyngitis—Doxorubicin—stomach cancer	0.000155	0.000578	CcSEcCtD
Etoricoxib—Decreased appetite—Docetaxel—stomach cancer	0.000155	0.000577	CcSEcCtD
Etoricoxib—Headache—Fluorouracil—stomach cancer	0.000154	0.000576	CcSEcCtD
Etoricoxib—Urinary tract disorder—Doxorubicin—stomach cancer	0.000154	0.000576	CcSEcCtD
Etoricoxib—Oedema peripheral—Doxorubicin—stomach cancer	0.000154	0.000574	CcSEcCtD
Etoricoxib—Dysgeusia—Methotrexate—stomach cancer	0.000154	0.000574	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000153	0.000573	CcSEcCtD
Etoricoxib—Connective tissue disorder—Doxorubicin—stomach cancer	0.000153	0.000573	CcSEcCtD
Etoricoxib—Dyspnoea—Capecitabine—stomach cancer	0.000153	0.000573	CcSEcCtD
Etoricoxib—Fatigue—Docetaxel—stomach cancer	0.000153	0.000572	CcSEcCtD
Etoricoxib—Angiopathy—Epirubicin—stomach cancer	0.000153	0.000572	CcSEcCtD
Etoricoxib—Urethral disorder—Doxorubicin—stomach cancer	0.000153	0.000571	CcSEcCtD
Etoricoxib—Nausea—Irinotecan—stomach cancer	0.000153	0.00057	CcSEcCtD
Etoricoxib—Immune system disorder—Epirubicin—stomach cancer	0.000152	0.000569	CcSEcCtD
Etoricoxib—Mediastinal disorder—Epirubicin—stomach cancer	0.000152	0.000568	CcSEcCtD
Etoricoxib—Constipation—Docetaxel—stomach cancer	0.000152	0.000567	CcSEcCtD
Etoricoxib—Pain—Docetaxel—stomach cancer	0.000152	0.000567	CcSEcCtD
Etoricoxib—Dyspepsia—Capecitabine—stomach cancer	0.000151	0.000565	CcSEcCtD
Etoricoxib—Arrhythmia—Epirubicin—stomach cancer	0.000151	0.000563	CcSEcCtD
Etoricoxib—Visual impairment—Doxorubicin—stomach cancer	0.00015	0.000562	CcSEcCtD
Etoricoxib—Decreased appetite—Capecitabine—stomach cancer	0.00015	0.000558	CcSEcCtD
Etoricoxib—Alopecia—Epirubicin—stomach cancer	0.000149	0.000557	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000149	0.000555	CcSEcCtD
Etoricoxib—Fatigue—Capecitabine—stomach cancer	0.000148	0.000554	CcSEcCtD
Etoricoxib—Vision blurred—Methotrexate—stomach cancer	0.000148	0.000552	CcSEcCtD
Etoricoxib—Mental disorder—Epirubicin—stomach cancer	0.000148	0.000552	CcSEcCtD
Etoricoxib—Erythema multiforme—Doxorubicin—stomach cancer	0.000148	0.000551	CcSEcCtD
Etoricoxib—Pain—Capecitabine—stomach cancer	0.000147	0.000549	CcSEcCtD
Etoricoxib—Constipation—Capecitabine—stomach cancer	0.000147	0.000549	CcSEcCtD
Etoricoxib—Erythema—Epirubicin—stomach cancer	0.000147	0.000548	CcSEcCtD
Etoricoxib—Malnutrition—Epirubicin—stomach cancer	0.000147	0.000548	CcSEcCtD
Etoricoxib—Feeling abnormal—Docetaxel—stomach cancer	0.000146	0.000547	CcSEcCtD
Etoricoxib—Nausea—Fluorouracil—stomach cancer	0.000146	0.000546	CcSEcCtD
Etoricoxib—Eye disorder—Doxorubicin—stomach cancer	0.000146	0.000545	CcSEcCtD
Etoricoxib—Tinnitus—Doxorubicin—stomach cancer	0.000146	0.000543	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Docetaxel—stomach cancer	0.000145	0.000543	CcSEcCtD
Etoricoxib—Anaemia—Methotrexate—stomach cancer	0.000145	0.000542	CcSEcCtD
Etoricoxib—Cardiac disorder—Doxorubicin—stomach cancer	0.000145	0.000541	CcSEcCtD
Etoricoxib—Flushing—Doxorubicin—stomach cancer	0.000145	0.000541	CcSEcCtD
Etoricoxib—Flatulence—Epirubicin—stomach cancer	0.000145	0.00054	CcSEcCtD
Etoricoxib—Dysgeusia—Epirubicin—stomach cancer	0.000144	0.000537	CcSEcCtD
Etoricoxib—Feeling abnormal—Capecitabine—stomach cancer	0.000142	0.000529	CcSEcCtD
Etoricoxib—Angiopathy—Doxorubicin—stomach cancer	0.000142	0.000529	CcSEcCtD
Etoricoxib—Muscle spasms—Epirubicin—stomach cancer	0.000141	0.000527	CcSEcCtD
Etoricoxib—Immune system disorder—Doxorubicin—stomach cancer	0.000141	0.000526	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Capecitabine—stomach cancer	0.000141	0.000525	CcSEcCtD
Etoricoxib—Mediastinal disorder—Doxorubicin—stomach cancer	0.000141	0.000525	CcSEcCtD
Etoricoxib—Abdominal pain—Docetaxel—stomach cancer	0.000141	0.000525	CcSEcCtD
Etoricoxib—Arrhythmia—Doxorubicin—stomach cancer	0.000139	0.000521	CcSEcCtD
Etoricoxib—Vision blurred—Epirubicin—stomach cancer	0.000138	0.000517	CcSEcCtD
Etoricoxib—Alopecia—Doxorubicin—stomach cancer	0.000138	0.000515	CcSEcCtD
Etoricoxib—Cough—Methotrexate—stomach cancer	0.000137	0.000511	CcSEcCtD
Etoricoxib—Mental disorder—Doxorubicin—stomach cancer	0.000137	0.000511	CcSEcCtD
Etoricoxib—Urticaria—Capecitabine—stomach cancer	0.000137	0.00051	CcSEcCtD
Etoricoxib—Abdominal pain—Capecitabine—stomach cancer	0.000136	0.000508	CcSEcCtD
Etoricoxib—Malnutrition—Doxorubicin—stomach cancer	0.000136	0.000507	CcSEcCtD
Etoricoxib—Erythema—Doxorubicin—stomach cancer	0.000136	0.000507	CcSEcCtD
Etoricoxib—Anaemia—Epirubicin—stomach cancer	0.000136	0.000507	CcSEcCtD
Etoricoxib—Agitation—Epirubicin—stomach cancer	0.000135	0.000504	CcSEcCtD
Etoricoxib—Flatulence—Doxorubicin—stomach cancer	0.000134	0.0005	CcSEcCtD
Etoricoxib—Arthralgia—Methotrexate—stomach cancer	0.000134	0.000499	CcSEcCtD
Etoricoxib—Chest pain—Methotrexate—stomach cancer	0.000134	0.000499	CcSEcCtD
Etoricoxib—Dysgeusia—Doxorubicin—stomach cancer	0.000133	0.000497	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000133	0.000495	CcSEcCtD
Etoricoxib—Hypersensitivity—Docetaxel—stomach cancer	0.000131	0.000489	CcSEcCtD
Etoricoxib—Muscle spasms—Doxorubicin—stomach cancer	0.000131	0.000488	CcSEcCtD
Etoricoxib—Palpitations—Epirubicin—stomach cancer	0.00013	0.000485	CcSEcCtD
Etoricoxib—Confusional state—Methotrexate—stomach cancer	0.000129	0.000482	CcSEcCtD
Etoricoxib—Cough—Epirubicin—stomach cancer	0.000128	0.000479	CcSEcCtD
Etoricoxib—Anaphylactic shock—Methotrexate—stomach cancer	0.000128	0.000478	CcSEcCtD
Etoricoxib—Vision blurred—Doxorubicin—stomach cancer	0.000128	0.000478	CcSEcCtD
Etoricoxib—Asthenia—Docetaxel—stomach cancer	0.000128	0.000476	CcSEcCtD
Etoricoxib—Infection—Methotrexate—stomach cancer	0.000127	0.000475	CcSEcCtD
Etoricoxib—Hypertension—Epirubicin—stomach cancer	0.000127	0.000473	CcSEcCtD
Etoricoxib—Hypersensitivity—Capecitabine—stomach cancer	0.000127	0.000473	CcSEcCtD
Etoricoxib—Pruritus—Docetaxel—stomach cancer	0.000126	0.000469	CcSEcCtD
Etoricoxib—Nervous system disorder—Methotrexate—stomach cancer	0.000126	0.000469	CcSEcCtD
Etoricoxib—Anaemia—Doxorubicin—stomach cancer	0.000126	0.000469	CcSEcCtD
Etoricoxib—Thrombocytopenia—Methotrexate—stomach cancer	0.000125	0.000468	CcSEcCtD
Etoricoxib—Chest pain—Epirubicin—stomach cancer	0.000125	0.000467	CcSEcCtD
Etoricoxib—Arthralgia—Epirubicin—stomach cancer	0.000125	0.000467	CcSEcCtD
Etoricoxib—Agitation—Doxorubicin—stomach cancer	0.000125	0.000466	CcSEcCtD
Etoricoxib—Anxiety—Epirubicin—stomach cancer	0.000125	0.000465	CcSEcCtD
Etoricoxib—Skin disorder—Methotrexate—stomach cancer	0.000124	0.000465	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000124	0.000464	CcSEcCtD
Etoricoxib—Asthenia—Capecitabine—stomach cancer	0.000123	0.000461	CcSEcCtD
Etoricoxib—Dry mouth—Epirubicin—stomach cancer	0.000122	0.000457	CcSEcCtD
Etoricoxib—Anorexia—Methotrexate—stomach cancer	0.000122	0.000456	CcSEcCtD
Etoricoxib—Pruritus—Capecitabine—stomach cancer	0.000122	0.000454	CcSEcCtD
Etoricoxib—Diarrhoea—Docetaxel—stomach cancer	0.000122	0.000454	CcSEcCtD
Etoricoxib—Confusional state—Epirubicin—stomach cancer	0.000121	0.000451	CcSEcCtD
Etoricoxib—Palpitations—Doxorubicin—stomach cancer	0.00012	0.000448	CcSEcCtD
Etoricoxib—Oedema—Epirubicin—stomach cancer	0.00012	0.000448	CcSEcCtD
Etoricoxib—Anaphylactic shock—Epirubicin—stomach cancer	0.00012	0.000448	CcSEcCtD
Etoricoxib—Infection—Epirubicin—stomach cancer	0.000119	0.000445	CcSEcCtD
Etoricoxib—Cough—Doxorubicin—stomach cancer	0.000119	0.000443	CcSEcCtD
Etoricoxib—Shock—Epirubicin—stomach cancer	0.000118	0.00044	CcSEcCtD
Etoricoxib—Diarrhoea—Capecitabine—stomach cancer	0.000118	0.00044	CcSEcCtD
Etoricoxib—Nervous system disorder—Epirubicin—stomach cancer	0.000118	0.000439	CcSEcCtD
Etoricoxib—Dizziness—Docetaxel—stomach cancer	0.000118	0.000439	CcSEcCtD
Etoricoxib—Thrombocytopenia—Epirubicin—stomach cancer	0.000117	0.000438	CcSEcCtD
Etoricoxib—Hypertension—Doxorubicin—stomach cancer	0.000117	0.000438	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000117	0.000436	CcSEcCtD
Etoricoxib—Skin disorder—Epirubicin—stomach cancer	0.000116	0.000435	CcSEcCtD
Etoricoxib—Insomnia—Methotrexate—stomach cancer	0.000116	0.000433	CcSEcCtD
Etoricoxib—Arthralgia—Doxorubicin—stomach cancer	0.000116	0.000432	CcSEcCtD
Etoricoxib—Chest pain—Doxorubicin—stomach cancer	0.000116	0.000432	CcSEcCtD
Etoricoxib—Anxiety—Doxorubicin—stomach cancer	0.000115	0.00043	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000115	0.000429	CcSEcCtD
Etoricoxib—Anorexia—Epirubicin—stomach cancer	0.000114	0.000427	CcSEcCtD
Etoricoxib—Dyspnoea—Methotrexate—stomach cancer	0.000114	0.000426	CcSEcCtD
Etoricoxib—Somnolence—Methotrexate—stomach cancer	0.000114	0.000425	CcSEcCtD
Etoricoxib—Dizziness—Capecitabine—stomach cancer	0.000114	0.000425	CcSEcCtD
Etoricoxib—Dry mouth—Doxorubicin—stomach cancer	0.000113	0.000422	CcSEcCtD
Etoricoxib—Vomiting—Docetaxel—stomach cancer	0.000113	0.000422	CcSEcCtD
Etoricoxib—Dyspepsia—Methotrexate—stomach cancer	0.000113	0.000421	CcSEcCtD
Etoricoxib—Rash—Docetaxel—stomach cancer	0.000112	0.000418	CcSEcCtD
Etoricoxib—Dermatitis—Docetaxel—stomach cancer	0.000112	0.000418	CcSEcCtD
Etoricoxib—Confusional state—Doxorubicin—stomach cancer	0.000112	0.000418	CcSEcCtD
Etoricoxib—Decreased appetite—Methotrexate—stomach cancer	0.000111	0.000416	CcSEcCtD
Etoricoxib—Headache—Docetaxel—stomach cancer	0.000111	0.000416	CcSEcCtD
Etoricoxib—Oedema—Doxorubicin—stomach cancer	0.000111	0.000414	CcSEcCtD
Etoricoxib—Anaphylactic shock—Doxorubicin—stomach cancer	0.000111	0.000414	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000111	0.000413	CcSEcCtD
Etoricoxib—Fatigue—Methotrexate—stomach cancer	0.00011	0.000412	CcSEcCtD
Etoricoxib—Infection—Doxorubicin—stomach cancer	0.00011	0.000411	CcSEcCtD
Etoricoxib—Pain—Methotrexate—stomach cancer	0.00011	0.000409	CcSEcCtD
Etoricoxib—Vomiting—Capecitabine—stomach cancer	0.000109	0.000408	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000109	0.000408	CcSEcCtD
Etoricoxib—Shock—Doxorubicin—stomach cancer	0.000109	0.000407	CcSEcCtD
Etoricoxib—Nervous system disorder—Doxorubicin—stomach cancer	0.000109	0.000406	CcSEcCtD
Etoricoxib—Thrombocytopenia—Doxorubicin—stomach cancer	0.000109	0.000405	CcSEcCtD
Etoricoxib—Rash—Capecitabine—stomach cancer	0.000109	0.000405	CcSEcCtD
Etoricoxib—Insomnia—Epirubicin—stomach cancer	0.000108	0.000405	CcSEcCtD
Etoricoxib—Dermatitis—Capecitabine—stomach cancer	0.000108	0.000405	CcSEcCtD
Etoricoxib—Headache—Capecitabine—stomach cancer	0.000108	0.000402	CcSEcCtD
Etoricoxib—Skin disorder—Doxorubicin—stomach cancer	0.000108	0.000402	CcSEcCtD
Etoricoxib—Dyspnoea—Epirubicin—stomach cancer	0.000107	0.000399	CcSEcCtD
Etoricoxib—Somnolence—Epirubicin—stomach cancer	0.000107	0.000398	CcSEcCtD
Etoricoxib—Anorexia—Doxorubicin—stomach cancer	0.000106	0.000395	CcSEcCtD
Etoricoxib—Nausea—Docetaxel—stomach cancer	0.000106	0.000394	CcSEcCtD
Etoricoxib—Feeling abnormal—Methotrexate—stomach cancer	0.000106	0.000394	CcSEcCtD
Etoricoxib—Dyspepsia—Epirubicin—stomach cancer	0.000106	0.000394	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Methotrexate—stomach cancer	0.000105	0.000391	CcSEcCtD
Etoricoxib—Decreased appetite—Epirubicin—stomach cancer	0.000104	0.000389	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000104	0.000386	CcSEcCtD
Etoricoxib—Fatigue—Epirubicin—stomach cancer	0.000103	0.000386	CcSEcCtD
Etoricoxib—Pain—Epirubicin—stomach cancer	0.000103	0.000383	CcSEcCtD
Etoricoxib—Constipation—Epirubicin—stomach cancer	0.000103	0.000383	CcSEcCtD
Etoricoxib—Nausea—Capecitabine—stomach cancer	0.000102	0.000382	CcSEcCtD
Etoricoxib—Urticaria—Methotrexate—stomach cancer	0.000102	0.00038	CcSEcCtD
Etoricoxib—Abdominal pain—Methotrexate—stomach cancer	0.000101	0.000378	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000101	0.000377	CcSEcCtD
Etoricoxib—Insomnia—Doxorubicin—stomach cancer	0.0001	0.000375	CcSEcCtD
Etoricoxib—Dyspnoea—Doxorubicin—stomach cancer	9.89e-05	0.000369	CcSEcCtD
Etoricoxib—Feeling abnormal—Epirubicin—stomach cancer	9.88e-05	0.000369	CcSEcCtD
Etoricoxib—Somnolence—Doxorubicin—stomach cancer	9.86e-05	0.000368	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Epirubicin—stomach cancer	9.8e-05	0.000366	CcSEcCtD
Etoricoxib—Dyspepsia—Doxorubicin—stomach cancer	9.76e-05	0.000365	CcSEcCtD
Etoricoxib—Decreased appetite—Doxorubicin—stomach cancer	9.64e-05	0.00036	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Doxorubicin—stomach cancer	9.58e-05	0.000358	CcSEcCtD
Etoricoxib—Fatigue—Doxorubicin—stomach cancer	9.56e-05	0.000357	CcSEcCtD
Etoricoxib—Urticaria—Epirubicin—stomach cancer	9.52e-05	0.000356	CcSEcCtD
Etoricoxib—Pain—Doxorubicin—stomach cancer	9.49e-05	0.000354	CcSEcCtD
Etoricoxib—Constipation—Doxorubicin—stomach cancer	9.49e-05	0.000354	CcSEcCtD
Etoricoxib—Abdominal pain—Epirubicin—stomach cancer	9.48e-05	0.000354	CcSEcCtD
Etoricoxib—Hypersensitivity—Methotrexate—stomach cancer	9.44e-05	0.000352	CcSEcCtD
Etoricoxib—Asthenia—Methotrexate—stomach cancer	9.19e-05	0.000343	CcSEcCtD
Etoricoxib—Feeling abnormal—Doxorubicin—stomach cancer	9.14e-05	0.000341	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Doxorubicin—stomach cancer	9.07e-05	0.000339	CcSEcCtD
Etoricoxib—Pruritus—Methotrexate—stomach cancer	9.06e-05	0.000338	CcSEcCtD
Etoricoxib—Hypersensitivity—Epirubicin—stomach cancer	8.83e-05	0.00033	CcSEcCtD
Etoricoxib—Urticaria—Doxorubicin—stomach cancer	8.81e-05	0.000329	CcSEcCtD
Etoricoxib—Abdominal pain—Doxorubicin—stomach cancer	8.77e-05	0.000327	CcSEcCtD
Etoricoxib—Diarrhoea—Methotrexate—stomach cancer	8.77e-05	0.000327	CcSEcCtD
Etoricoxib—Asthenia—Epirubicin—stomach cancer	8.6e-05	0.000321	CcSEcCtD
Etoricoxib—Pruritus—Epirubicin—stomach cancer	8.48e-05	0.000317	CcSEcCtD
Etoricoxib—Dizziness—Methotrexate—stomach cancer	8.47e-05	0.000316	CcSEcCtD
Etoricoxib—Diarrhoea—Epirubicin—stomach cancer	8.2e-05	0.000306	CcSEcCtD
Etoricoxib—Hypersensitivity—Doxorubicin—stomach cancer	8.17e-05	0.000305	CcSEcCtD
Etoricoxib—Vomiting—Methotrexate—stomach cancer	8.15e-05	0.000304	CcSEcCtD
Etoricoxib—Rash—Methotrexate—stomach cancer	8.08e-05	0.000302	CcSEcCtD
Etoricoxib—Dermatitis—Methotrexate—stomach cancer	8.07e-05	0.000301	CcSEcCtD
Etoricoxib—Headache—Methotrexate—stomach cancer	8.03e-05	0.0003	CcSEcCtD
Etoricoxib—Asthenia—Doxorubicin—stomach cancer	7.96e-05	0.000297	CcSEcCtD
Etoricoxib—Dizziness—Epirubicin—stomach cancer	7.93e-05	0.000296	CcSEcCtD
Etoricoxib—Pruritus—Doxorubicin—stomach cancer	7.85e-05	0.000293	CcSEcCtD
Etoricoxib—Vomiting—Epirubicin—stomach cancer	7.62e-05	0.000285	CcSEcCtD
Etoricoxib—Nausea—Methotrexate—stomach cancer	7.61e-05	0.000284	CcSEcCtD
Etoricoxib—Diarrhoea—Doxorubicin—stomach cancer	7.59e-05	0.000283	CcSEcCtD
Etoricoxib—Rash—Epirubicin—stomach cancer	7.56e-05	0.000282	CcSEcCtD
Etoricoxib—Dermatitis—Epirubicin—stomach cancer	7.55e-05	0.000282	CcSEcCtD
Etoricoxib—Headache—Epirubicin—stomach cancer	7.51e-05	0.00028	CcSEcCtD
Etoricoxib—Dizziness—Doxorubicin—stomach cancer	7.34e-05	0.000274	CcSEcCtD
Etoricoxib—Nausea—Epirubicin—stomach cancer	7.12e-05	0.000266	CcSEcCtD
Etoricoxib—Vomiting—Doxorubicin—stomach cancer	7.05e-05	0.000263	CcSEcCtD
Etoricoxib—Rash—Doxorubicin—stomach cancer	6.99e-05	0.000261	CcSEcCtD
Etoricoxib—Dermatitis—Doxorubicin—stomach cancer	6.99e-05	0.000261	CcSEcCtD
Etoricoxib—Headache—Doxorubicin—stomach cancer	6.95e-05	0.000259	CcSEcCtD
Etoricoxib—Nausea—Doxorubicin—stomach cancer	6.59e-05	0.000246	CcSEcCtD
Etoricoxib—CYP2D6—Metabolism—ALDOB—stomach cancer	1.56e-05	6.9e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—stomach cancer	1.56e-05	6.89e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PLIN2—stomach cancer	1.55e-05	6.87e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—DPYD—stomach cancer	1.55e-05	6.86e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ALDOB—stomach cancer	1.55e-05	6.84e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—FYN—stomach cancer	1.54e-05	6.81e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—FADS1—stomach cancer	1.52e-05	6.74e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TYMP—stomach cancer	1.52e-05	6.74e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—HRAS—stomach cancer	1.52e-05	6.72e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CA2—stomach cancer	1.51e-05	6.68e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—HRAS—stomach cancer	1.49e-05	6.59e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SMAD4—stomach cancer	1.48e-05	6.55e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CD44—stomach cancer	1.48e-05	6.54e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NT5E—stomach cancer	1.47e-05	6.51e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PGAM1—stomach cancer	1.47e-05	6.51e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.46e-05	6.45e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.45e-05	6.44e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6—stomach cancer	1.45e-05	6.43e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—PIK3CA—stomach cancer	1.45e-05	6.42e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ALOX5—stomach cancer	1.45e-05	6.42e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—FGFR2—stomach cancer	1.44e-05	6.39e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ALOX5—stomach cancer	1.44e-05	6.36e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SREBF2—stomach cancer	1.43e-05	6.31e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—DPYD—stomach cancer	1.43e-05	6.31e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—DPYD—stomach cancer	1.41e-05	6.26e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—RORA—stomach cancer	1.41e-05	6.24e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.4e-05	6.22e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—FYN—stomach cancer	1.4e-05	6.21e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ERBB2—stomach cancer	1.4e-05	6.21e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.4e-05	6.21e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PLCE1—stomach cancer	1.4e-05	6.21e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTT1—stomach cancer	1.37e-05	6.07e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP2A6—stomach cancer	1.35e-05	6e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ERCC2—stomach cancer	1.35e-05	5.97e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—UMPS—stomach cancer	1.34e-05	5.95e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—HRAS—stomach cancer	1.34e-05	5.94e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PPP2R1A—stomach cancer	1.33e-05	5.9e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IRS2—stomach cancer	1.32e-05	5.86e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALDOB—stomach cancer	1.32e-05	5.85e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AKR1C3—stomach cancer	1.32e-05	5.83e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—FGFR2—stomach cancer	1.32e-05	5.83e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GSTP1—stomach cancer	1.31e-05	5.79e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CDKN1B—stomach cancer	1.3e-05	5.75e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—HMOX1—stomach cancer	1.29e-05	5.71e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ENO1—stomach cancer	1.28e-05	5.69e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6—stomach cancer	1.28e-05	5.68e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CAV1—stomach cancer	1.28e-05	5.68e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.28e-05	5.67e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—APOA1—stomach cancer	1.28e-05	5.67e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1B—stomach cancer	1.28e-05	5.65e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MTHFR—stomach cancer	1.27e-05	5.62e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.26e-05	5.59e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTT1—stomach cancer	1.26e-05	5.58e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PPP2R1A—stomach cancer	1.26e-05	5.56e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ECHS1—stomach cancer	1.25e-05	5.53e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PDHA1—stomach cancer	1.25e-05	5.53e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTT1—stomach cancer	1.25e-05	5.53e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP2A6—stomach cancer	1.25e-05	5.52e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.25e-05	5.51e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.24e-05	5.5e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—JUN—stomach cancer	1.24e-05	5.48e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP2A6—stomach cancer	1.24e-05	5.47e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GSTP1—stomach cancer	1.23e-05	5.45e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALOX5—stomach cancer	1.23e-05	5.43e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PRKCB—stomach cancer	1.22e-05	5.4e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—TYMS—stomach cancer	1.22e-05	5.38e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6ST—stomach cancer	1.22e-05	5.38e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—HMOX1—stomach cancer	1.21e-05	5.38e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AKR1C3—stomach cancer	1.21e-05	5.37e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—DPYD—stomach cancer	1.21e-05	5.35e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IRS2—stomach cancer	1.21e-05	5.34e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GSTM1—stomach cancer	1.2e-05	5.32e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AKR1C3—stomach cancer	1.2e-05	5.32e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CDKN1A—stomach cancer	1.2e-05	5.31e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ENO1—stomach cancer	1.18e-05	5.23e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—FADS1—stomach cancer	1.18e-05	5.2e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TYMP—stomach cancer	1.18e-05	5.2e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ENO1—stomach cancer	1.17e-05	5.18e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MAPK8—stomach cancer	1.17e-05	5.18e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CAV1—stomach cancer	1.17e-05	5.18e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—APC—stomach cancer	1.17e-05	5.17e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—APOA1—stomach cancer	1.17e-05	5.17e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.15e-05	5.1e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—TYMS—stomach cancer	1.14e-05	5.07e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CD44—stomach cancer	1.14e-05	5.04e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GSTM1—stomach cancer	1.13e-05	5.01e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ERCC2—stomach cancer	1.13e-05	5e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6ST—stomach cancer	1.11e-05	4.91e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.11e-05	4.89e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SREBF2—stomach cancer	1.1e-05	4.87e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.09e-05	4.85e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—RORA—stomach cancer	1.09e-05	4.81e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6R—stomach cancer	1.08e-05	4.8e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—STAT3—stomach cancer	1.07e-05	4.74e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTT1—stomach cancer	1.07e-05	4.73e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—APC—stomach cancer	1.07e-05	4.72e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ERCC2—stomach cancer	1.06e-05	4.71e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—MTHFR—stomach cancer	1.06e-05	4.7e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP2A6—stomach cancer	1.06e-05	4.67e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CD44—stomach cancer	1.05e-05	4.64e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CD44—stomach cancer	1.04e-05	4.6e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AKR1C3—stomach cancer	1.03e-05	4.55e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MAPK3—stomach cancer	1.02e-05	4.53e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALDOB—stomach cancer	1.02e-05	4.51e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—MAPK3—stomach cancer	1.02e-05	4.5e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SERPINE1—stomach cancer	1.02e-05	4.5e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.01e-05	4.46e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ENO1—stomach cancer	1e-05	4.43e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MTHFR—stomach cancer	1e-05	4.43e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6R—stomach cancer	9.9e-06	4.38e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—MYC—stomach cancer	9.89e-06	4.38e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	9.84e-06	4.36e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CAV1—stomach cancer	9.8e-06	4.34e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RHOA—stomach cancer	9.8e-06	4.34e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—APOA1—stomach cancer	9.78e-06	4.33e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MAPK1—stomach cancer	9.73e-06	4.31e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—EGFR—stomach cancer	9.73e-06	4.31e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NOS3—stomach cancer	9.7e-06	4.29e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PPP2R1A—stomach cancer	9.69e-06	4.29e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTP1—stomach cancer	9.5e-06	4.21e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALOX5—stomach cancer	9.47e-06	4.19e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—HMOX1—stomach cancer	9.37e-06	4.15e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.36e-06	4.14e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—DPYD—stomach cancer	9.32e-06	4.13e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SERPINE1—stomach cancer	9.27e-06	4.1e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CAV1—stomach cancer	9.22e-06	4.08e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—APOA1—stomach cancer	9.2e-06	4.07e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—KRAS—stomach cancer	9.19e-06	4.07e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ERBB2—stomach cancer	9.07e-06	4.02e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—RHOA—stomach cancer	8.94e-06	3.96e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PPP2R1A—stomach cancer	8.91e-06	3.94e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CD44—stomach cancer	8.88e-06	3.93e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS3—stomach cancer	8.85e-06	3.92e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—TYMS—stomach cancer	8.83e-06	3.91e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PPP2R1A—stomach cancer	8.83e-06	3.91e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTP1—stomach cancer	8.74e-06	3.87e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTM1—stomach cancer	8.73e-06	3.86e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTP1—stomach cancer	8.66e-06	3.83e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—HMOX1—stomach cancer	8.62e-06	3.81e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PPARG—stomach cancer	8.61e-06	3.81e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	8.61e-06	3.81e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL8—stomach cancer	8.6e-06	3.81e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—HMOX1—stomach cancer	8.54e-06	3.78e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PIK3CA—stomach cancer	8.44e-06	3.74e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CDKN1B—stomach cancer	8.4e-06	3.72e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ERBB2—stomach cancer	8.28e-06	3.66e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTT1—stomach cancer	8.24e-06	3.65e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ERCC2—stomach cancer	8.21e-06	3.63e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP2A6—stomach cancer	8.15e-06	3.61e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—TYMS—stomach cancer	8.12e-06	3.6e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PPARG—stomach cancer	8.11e-06	3.59e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—TYMS—stomach cancer	8.05e-06	3.57e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTM1—stomach cancer	8.03e-06	3.55e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCND1—stomach cancer	8.01e-06	3.55e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—JUN—stomach cancer	8e-06	3.54e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTM1—stomach cancer	7.96e-06	3.52e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AKR1C3—stomach cancer	7.93e-06	3.51e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HRAS—stomach cancer	7.81e-06	3.46e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MMP9—stomach cancer	7.78e-06	3.44e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CDKN1A—stomach cancer	7.75e-06	3.43e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ALB—stomach cancer	7.75e-06	3.43e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ENO1—stomach cancer	7.72e-06	3.42e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MTHFR—stomach cancer	7.72e-06	3.42e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CDKN1B—stomach cancer	7.66e-06	3.39e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MAPK8—stomach cancer	7.57e-06	3.35e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ERCC2—stomach cancer	7.55e-06	3.34e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PPP2R1A—stomach cancer	7.55e-06	3.34e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ERCC2—stomach cancer	7.48e-06	3.31e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—stomach cancer	7.47e-06	3.31e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—NOS3—stomach cancer	7.41e-06	3.28e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTP1—stomach cancer	7.4e-06	3.28e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HMOX1—stomach cancer	7.3e-06	3.23e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ALB—stomach cancer	7.29e-06	3.23e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CAV1—stomach cancer	7.12e-06	3.15e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—APOA1—stomach cancer	7.1e-06	3.14e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MTHFR—stomach cancer	7.1e-06	3.14e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CDKN1A—stomach cancer	7.07e-06	3.13e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MTHFR—stomach cancer	7.04e-06	3.11e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VEGFA—stomach cancer	6.99e-06	3.09e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—NOS3—stomach cancer	6.97e-06	3.09e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—STAT3—stomach cancer	6.92e-06	3.06e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TYMS—stomach cancer	6.88e-06	3.05e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CD44—stomach cancer	6.85e-06	3.03e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTM1—stomach cancer	6.8e-06	3.01e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.8e-06	3.01e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MAPK3—stomach cancer	6.61e-06	2.93e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CAV1—stomach cancer	6.55e-06	2.9e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—APOA1—stomach cancer	6.53e-06	2.89e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CAV1—stomach cancer	6.49e-06	2.87e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—APOA1—stomach cancer	6.47e-06	2.87e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MYC—stomach cancer	6.43e-06	2.85e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ERCC2—stomach cancer	6.4e-06	2.83e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—stomach cancer	6.38e-06	2.82e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—STAT3—stomach cancer	6.31e-06	2.79e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MAPK1—stomach cancer	6.29e-06	2.78e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EGFR—stomach cancer	6.29e-06	2.78e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PPARG—stomach cancer	6.26e-06	2.77e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.2e-06	2.74e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MAPK3—stomach cancer	6.03e-06	2.67e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MTHFR—stomach cancer	6.01e-06	2.66e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KRAS—stomach cancer	5.94e-06	2.63e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MYC—stomach cancer	5.86e-06	2.6e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPP2R1A—stomach cancer	5.82e-06	2.58e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PPARG—stomach cancer	5.75e-06	2.55e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MAPK1—stomach cancer	5.74e-06	2.54e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—EGFR—stomach cancer	5.74e-06	2.54e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTP1—stomach cancer	5.71e-06	2.53e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PPARG—stomach cancer	5.7e-06	2.53e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HMOX1—stomach cancer	5.63e-06	2.49e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ALB—stomach cancer	5.63e-06	2.49e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CAV1—stomach cancer	5.55e-06	2.45e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—APOA1—stomach cancer	5.53e-06	2.45e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PIK3CA—stomach cancer	5.46e-06	2.42e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—KRAS—stomach cancer	5.42e-06	2.4e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NOS3—stomach cancer	5.38e-06	2.38e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TYMS—stomach cancer	5.31e-06	2.35e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.3e-06	2.35e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—stomach cancer	5.28e-06	2.34e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTM1—stomach cancer	5.25e-06	2.32e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ALB—stomach cancer	5.17e-06	2.29e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ALB—stomach cancer	5.13e-06	2.27e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HRAS—stomach cancer	5.05e-06	2.24e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PIK3CA—stomach cancer	4.98e-06	2.2e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NOS3—stomach cancer	4.95e-06	2.19e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ERCC2—stomach cancer	4.94e-06	2.19e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—stomach cancer	4.92e-06	2.18e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NOS3—stomach cancer	4.91e-06	2.17e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PPARG—stomach cancer	4.87e-06	2.16e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—stomach cancer	4.83e-06	2.14e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MTHFR—stomach cancer	4.64e-06	2.05e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HRAS—stomach cancer	4.61e-06	2.04e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—stomach cancer	4.53e-06	2e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—stomach cancer	4.49e-06	1.99e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—stomach cancer	4.41e-06	1.95e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALB—stomach cancer	4.38e-06	1.94e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CAV1—stomach cancer	4.28e-06	1.89e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—APOA1—stomach cancer	4.27e-06	1.89e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NOS3—stomach cancer	4.19e-06	1.86e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PIK3CA—stomach cancer	4.17e-06	1.85e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PIK3CA—stomach cancer	3.92e-06	1.74e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—stomach cancer	3.83e-06	1.7e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPARG—stomach cancer	3.76e-06	1.67e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALB—stomach cancer	3.38e-06	1.5e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NOS3—stomach cancer	3.24e-06	1.43e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PIK3CA—stomach cancer	3.03e-06	1.34e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—stomach cancer	2.96e-06	1.31e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.79e-06	1.23e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PIK3CA—stomach cancer	2.76e-06	1.22e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PIK3CA—stomach cancer	2.36e-06	1.04e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.82e-06	8.06e-06	CbGpPWpGaD
